Every year, the World Hepatitis Day brings the world together to focus on the theme of raising awareness about the global burden of viral hepatitis (inflammation of the liver), and to advocate for real change. EASL calls on the global…
The curative potential of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection have transformed hepatology in recent years. However, the challenge of identifying more people living with HCV remains, and further progress is needed with other forms of viral…
Researchers at EF Clif identify three different clinical courses for the first time, in patients with acute decompensated cirrhosis without acute-on-chronic liver failure (ACLF). July 14, 2020 – A clinical study led by the European Foundation for the Study of…
ClarivateTM Analytics released the 2020 update of its Journal Citation Reports©, including the much anticipated 2019 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology, achieved unprecedented results with a 2019 impact factor of 20.582, up from the 2018…
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden published in the Journal of Hepatology. The risk of…
This is the ideal opportunity for you to learn from some of the biggest names in hepatology and meet them in an engaging & interactive setting!
Scientists have identified a microRNA in obese mouse mothers that may increase the odds of liver cancer in their offspring throughout multiple generations, report scientists in the Journal of Hepatology. Amsterdam, June 25, 2020 – Scientists recognise the connection between…
EASL has been actively working to beat liver disease, including NAFLD & NASH, through its schools and key event, the NAFLD Summit. EASL has also developed a Policy Statement on the measures required to prevent and treat this common progressive…
Women with non-alcoholic fatty liver disease (NAFLD) should receive preconception counselling on increased maternal and infant risks, while pregnant mothers may benefit from evaluation by a high-risk obstetrics team, recommend scientists in the Journal of Hepatology. Oxford, June 9, 2020…
